5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Sell
39
VNDA Quote, Financials, Valuation and Earnings
Last price:
$4.23
Seasonality move
:
84.65%
Day range:
$4.30 - $4.45
52-week range:
$3.85 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.28x
P/B ratio:
0.47x
Volume:
574.6K
Avg. volume:
641.5K
1-year change:
-20.07%
Market cap:
$255.4M
Revenue:
$198.8M
EPS (TTM):
-$0.32
VNDA Analysts' Consensus Rating
The 2 analysts providing 12-month price projections for Vanda Pharmaceuticals shares anticipate an average target of $12.67, ranging from a low estimate of $5.00 to a high estimate of $20.00. This average target implies a growth of 189.19% compared to the current stock price of $4.38.
Consensus Price Target
$12.67
Highest Price Target
$20.00
Lowest Price Target
$5.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Leans Bullish | Leans Bullish | Leans Bullish |
VNDA Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 8
Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.
Buy
92
TPB alert for May 8
Turning Point Brands [TPB] is down 6.67% over the past day.
Buy
74
LIVN alert for May 8
LivaNova PLC [LIVN] is up 1.33% over the past day.
